Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02NDC
|
|||
| Former ID |
DIB008241
|
|||
| Drug Name |
GSK-2202083A
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 2 | [1] | |
| Company |
GlaxoSmithKline Biologicals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01090453) Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.